Slides on Key Decisions in HIV Care: Considering the Use of Proviral DNA Genotyping to Inform ART Choice

Learn the data and recommendations for the use of proviral HIV DNA genotyping to inform ART choice for patients with significant ART experience.
John D. Baxter, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 246 KB
Released: January 24, 2022

Acknowledgements

Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings